Aclaris Therapeutics, Inc. (ACRS) Profit Margins
Over the twelve months to 2026-06-30, Aclaris Therapeutics, Inc. (ACRS) had gross margin 79.5%, operating margin -1050.2%, net margin -921.5%, free cash flow margin -756.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ACRSAclaris Therapeutics, Inc.Follow ACRS — free
—
Price chart with a free account
- Market cap
- 552.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 28.3% | 52.7% | 4.1% | 20.8% | 30.3% | 86.5% | 89.0% | 85.1% | 73.3% | 79.5% | |
| Operating margin | -3230.0% | -1378.3% | -2627.3% | -785.4% | -1327.1% | -302.0% | -311.6% | -758.2% | -975.9% | -1050.2% | |
| Net margin | -4071.5% | -2158.0% | -3817.2% | -787.0% | -1344.0% | -292.1% | -283.1% | -705.5% | -829.6% | -921.5% | |
| FCF margin | -3321.3% | -1661.0% | -2319.8% | -603.0% | -775.7% | -229.1% | -254.8% | -107.9% | -603.4% | -756.5% |
USD millions · SEC XBRL
Aclaris Therapeutics, Inc. — questions
- What is Aclaris Therapeutics, Inc.'s gross margin?
- 79.5% over the twelve months to 2026-06-30.
- What is Aclaris Therapeutics, Inc.'s operating margin?
- -1050.2% over the twelve months to 2026-06-30.
- What is Aclaris Therapeutics, Inc.'s net profit margin?
- -921.5% over the twelve months to 2026-06-30.
Every figure on this page comes from Aclaris Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.